At the time of writing, ATAI Life Sciences N.V [ATAI] stock is trading at $4.17, up 1.71%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ATAI shares have gain 16.81% over the last week, with a monthly amount glided 51.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ATAI Life Sciences N.V [NASDAQ: ATAI] stock has seen the most recent analyst activity on July 29, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $14. Previously, H.C. Wainwright reaffirmed its Buy rating on November 18, 2024, and dropped its price target to $10. On April 03, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $6 on the stock. Loop Capital started tracking the stock assigning a Buy rating and suggested a price target of $18 on November 01, 2022. Maxim Group initiated its recommendation with a Buy and recommended $25 as its price target on November 30, 2021. ROTH Capital started tracking with a Buy rating for this stock on November 11, 2021, and assigned it a price target of $32. In a note dated October 18, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $40 on this stock.
For the past year, the stock price of ATAI Life Sciences N.V fluctuated between $1.03 and $4.29. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. ATAI Life Sciences N.V [NASDAQ: ATAI] shares were valued at $4.17 at the most recent close of the market. An investor can expect a potential return of 19.9% based on the average ATAI price forecast.
Analyzing the ATAI fundamentals
According to ATAI Life Sciences N.V [NASDAQ:ATAI], the company’s sales were 0.33M for trailing twelve months, which represents an 8538.89% jump. Gross Profit Margin for this corporation currently stands at 0.88% with Operating Profit Margin at -53.12%, Pretax Profit Margin comes in at -80.14%, and Net Profit Margin reading is -79.97%. To continue investigating profitability, this company’s Return on Assets is posted at -0.76, Equity is -1.02 and Total Capital is -0.59. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.90 points at the first support level, and at 3.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.36, and for the 2nd resistance point, it is at 4.54.
Ratios To Look Out For
It is important to note that ATAI Life Sciences N.V [NASDAQ:ATAI] has a current ratio of 4.07. Also, the Quick Ratio is 4.07, while the Cash Ratio stands at 1.69. Considering the valuation of this stock, the price to sales ratio is 2536.79, the price to book ratio is 5.48.
Transactions by insiders
Recent insider trading involved SAHIL KIRPEKAR, Officer, that happened on Jul 02 ’25 when 83332.0 shares were purchased. Officer, SAHIL KIRPEKAR completed a deal on Jul 01 ’25 to buy 0.11 million shares. Meanwhile, Officer SAHIL KIRPEKAR bought 80000.0 shares on Jun 04 ’25.
